SCANPHARM A/S — Credit Rating and Financial Key Figures
CVR number: 16279099
Topstykket 12, 3460 Birkerød
tel: 45826046
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 17 829.89 | 5 118.41 | 11 259.43 | 17 399.14 | 22 519.43 |
| Employee benefit expenses | -19 495.44 | -19 391.00 | -18 905.94 | -21 127.92 | -24 334.74 |
| Other operating expenses | - 334.46 | - 334.46 | |||
| Total depreciation | -1 564.25 | -1 823.49 | -1 737.32 | -1 810.61 | -1 717.31 |
| EBIT | -3 229.81 | -16 096.07 | -9 718.29 | -5 204.94 | -3 532.62 |
| Other financial income | 33.08 | 33.11 | |||
| Other financial expenses | - 780.99 | -1 035.88 | -1 305.70 | -1 407.55 | - 986.17 |
| Pre-tax profit | -3 977.72 | -17 098.85 | -10 784.66 | -6 105.89 | -4 424.69 |
| Income taxes | -1 842.45 | -85.92 | 151.43 | ||
| Net earnings | -3 977.72 | -18 941.30 | -10 870.59 | -5 954.45 | -4 424.69 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Goodwill | 502.16 | 392.97 | 283.78 | 137.58 | 41.08 |
| Intangible assets total | 502.16 | 392.97 | 283.78 | 137.58 | 41.08 |
| Buildings | 16 050.20 | 14 637.45 | 13 673.97 | 13 081.61 | 13 724.56 |
| Machinery and equipment | 514.03 | 436.53 | 359.40 | 313.60 | 275.59 |
| Tangible assets total | 16 564.23 | 15 073.98 | 14 033.38 | 13 395.21 | 14 000.15 |
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 4 331.69 | 2 992.71 | 2 725.76 | 5 840.96 | 8 317.13 |
| Finished products/goods | 4 385.04 | 3 309.88 | 2 502.80 | 717.12 | 880.75 |
| Advance payments | 551.51 | ||||
| Inventories total | 8 716.73 | 6 302.59 | 5 228.56 | 6 558.08 | 9 749.40 |
| Current amounts owed by group member comp. | 276.21 | ||||
| Current other receivables | 6 445.76 | 9 640.47 | 8 636.88 | 8 688.14 | 6 930.89 |
| Current deferred tax assets | 2 656.94 | 814.49 | 728.57 | 880.00 | 880.00 |
| Short term receivables total | 9 378.91 | 10 454.96 | 9 365.45 | 9 568.14 | 7 810.89 |
| Balance sheet total (assets) | 35 162.04 | 32 224.49 | 28 911.17 | 29 659.02 | 31 601.52 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 |
| Asset revaluation reserve | 1 551.89 | 1 488.24 | 1 424.59 | 1 360.94 | 1 297.30 |
| Retained earnings | 5 315.12 | 16 366.20 | 7 945.99 | 3 093.51 | 1 627.39 |
| Profit of the financial year | -3 977.72 | -18 941.30 | -10 870.59 | -5 954.45 | -4 424.69 |
| Shareholders equity total | 5 889.29 | 1 913.14 | 1 500.00 | 1 500.00 | 1 500.00 |
| Non-current leasing loans | 4 497.13 | 3 600.93 | 2 408.89 | 1 478.59 | 2 264.21 |
| Non-current other liabilities | 1 579.82 | 1 537.00 | 1 428.65 | 1 361.09 | |
| Non-current liabilities total | 4 497.13 | 5 180.76 | 3 945.89 | 2 907.24 | 3 625.29 |
| Current loans from credit institutions | 12 567.93 | 13 773.65 | 12 360.79 | 8 094.00 | 9 976.21 |
| Advances received | 1 579.29 | 129.95 | 348.62 | 1 119.10 | |
| Current trade creditors | 2 076.29 | 7 652.35 | 4 738.44 | 3 763.81 | 4 253.34 |
| Current owed to participating | 5 119.77 | ||||
| Current owed to group member | 4 182.55 | 9 154.23 | 7 967.04 | ||
| Other non-interest bearing current liabilities | 3 432.34 | 3 574.66 | 1 834.89 | 3 120.63 | 4 279.64 |
| Current liabilities total | 24 775.63 | 25 130.60 | 23 465.28 | 25 251.78 | 26 476.22 |
| Balance sheet total (liabilities) | 35 162.04 | 32 224.49 | 28 911.17 | 29 659.02 | 31 601.52 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.